Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Gancberg

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Clinical Breast Cancer|January 21, 2003
Microtubule-associated parameters as predictive markers of docetaxel activity in advanced breast cancer patients: results of a pilot studyChantal Bernard-Marty, Isabelle Treilleux, Charles Dumontet, et al.
Electrophoresis|August 21, 2007
A study of comparability in amplified fragment length polymorphism profiling using a simple model systemLina Partis, Malcolm Burns, Koichi Chiba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Class III beta-tubulin isotype predicts response in advanced breast cancer patients randomly treated either with single-agent doxorubicin or docetaxelCarlos M Galmarini, Isabelle Treilleux, Fatima Cardoso, et al.
Clinical Chemistry and Laboratory Medicine|October 6, 2005
Reference materials (RMs) for analysis of the human factor II (prothrombin) gene G20210A mutationChristoph L Klein, János Márki-Zay, Philippe Corbisier, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Clinical Breast Cancer|January 21, 2003
Microtubule-associated parameters as predictive markers of docetaxel activity in advanced breast cancer patients: results of a pilot studyChantal Bernard-Marty, Isabelle Treilleux, Charles Dumontet, et al.
Electrophoresis|August 21, 2007
A study of comparability in amplified fragment length polymorphism profiling using a simple model systemLina Partis, Malcolm Burns, Koichi Chiba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Class III beta-tubulin isotype predicts response in advanced breast cancer patients randomly treated either with single-agent doxorubicin or docetaxelCarlos M Galmarini, Isabelle Treilleux, Fatima Cardoso, et al.
Clinical Chemistry and Laboratory Medicine|October 6, 2005
Reference materials (RMs) for analysis of the human factor II (prothrombin) gene G20210A mutationChristoph L Klein, János Márki-Zay, Philippe Corbisier, et al.
Pageof 2